Crossref
Africa may lead rollout of long-lasting HIV drug
Science · 2024
DOI: 10.1126/science.adp4711 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, 2024. Verfasst von Jon Cohen. Hauptthemen laut MEDLINE: HIV Infections, Anti-HIV Agents, Pre-Exposure Prophylaxis. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
U.S. agency plans to make inexpensive prevention shots widely available for people at risk
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
HIV InfectionsAnti-HIV AgentsPre-Exposure ProphylaxisHumansAfrica South of the SaharaDelayed-Action PreparationsMaleFemaleInjections
Substanzen
Anti-HIV AgentsDelayed-Action Preparations
Zitieren
APA
Cohen, J. (2024). Africa may lead rollout of long-lasting HIV drug. Science. https://doi.org/10.1126/science.adp4711
Vancouver
Cohen J. Africa may lead rollout of long-lasting HIV drug. Science. 2024. doi:10.1126/science.adp4711
BibTeX
@article{Cohen2024,
author = {Cohen, Jon},
title = {Africa may lead rollout of long-lasting HIV drug},
journal = {Science},
year = {2024},
doi = {10.1126/science.adp4711}
}
EUVIMED